Table of Contents:
  • Screening and Toxicity of Anti-Inflammatory Drugs
  • 19 Screening and Assessment of the Potency of Anti-Inflammatory Drugs in vitro
  • 20 Inhibition of Erythema and Local Hyperthermia
  • 21 Oedema and Increased Vascular Permeability
  • 22 Short-Term Drug Control of Crystal-Induced Inflammation
  • 23 Experimental Models of Arthritis in Animals as Screening Tests for Drugs to Treat Arthritis in Man
  • 24 Antagonism of Bradykinin Bronchoconstriction by Anti-Inflammatory Drugs
  • 25 Interference of Anti-Inflammatory Drugs With Hypotension
  • 26 Antagonism of Pain and Hyperalgesia
  • 27 Inhibition of Cell Migration in vivo and Granuloma Formation
  • 28 Inhibition of Fever
  • 29 Evaluation of the Toxicity of Anti-Inflammatory Drugs
  • Pharmacology of the Anti-Inflammatory Agents
  • 30 Prostaglandin Synthetase Inhibitors I
  • 31 Mode of Action of Anti-Inflammatory Agents Which are Prostaglandin Synthetase Inhibitors
  • 32 Penicillamine and Drugs With a Specific Action in Rheumatoid Arthritis
  • 33 Antagonists of Histamine, 5-Hydroxytryptamine and SRSA
  • 34 Inhibitors of the Release of Anaphylatic Mediators
  • 35 Cytostats With Effects in Chronic Inflammation
  • 36 Control of Hyperuricemia
  • 37 Anti-Inflammatory Steroids: Mode of Action in Rheumatoid Arthritis and Homograft Reaction
  • 38 Anti-Inflammatory Agents of Animal Origin
  • 39 Anti-Inflammatory Substances of Plant Origin
  • 40 A Critical Comparison of the Evaluation of Anti-Inflammatory Therapy in Animal Models and Man
  • Author Index.